Australian drugmaker's decade-long journey ends in FDA approval

Australian drugmaker Clinuvel on Tuesday won U.S. approval for a drug designed to treat a rare skin disease that causes painful sensitivity to light, capping more than a decade of development by the Melbourne-based company.